Contact
searchSearch
HMP Global

CME Conference Calendar

Learn More
September 17 - September 21, 2025
Visit Our Newsroom
Learn More
October 03 - October 05, 2025
Learn More
April 03 - April 04, 2025
May 01 - May 02, 2025
July 17 - July 18, 2025
August 07 - August 08, 2025
October 09 - October 10, 2025
November 20 - November 21, 2025
Visit Our Newsroom
Learn More
November 06 - November 09, 2025
May 01 - May 03, 2026
Visit Our Newsroom
Learn More
June 12 - June 13, 2025
August 14 - August 15, 2025
December 04 - December 05, 2025
Visit Our Newsroom
Learn More
December 08 - December 10, 2025
Visit Our Newsroom
Learn More
December 15 - December 18, 2025
Visit Our Newsroom
Learn More
March 19 - March 22, 2026
Learn More
April 06 - April 09, 2026
Visit Our Newsroom
Learn More
May 28 - May 30, 2026
Learn More
June 03 - June 06, 2026
Visit Our Newsroom

Popular Now

bipolar disorder graphic
News
Metformin Helps Prevent Weight Gain in Youth Taking Medication for Bipolar Disorder
11/15/2023
Jolynn Tumolo
The type 2 diabetes drug metformin can help prevent, and in some cases reverse, weight gain in youth taking second-generation antipsychotics (SGAs) for BD, according to short-term data from a large-scale trial.
The type 2 diabetes drug metformin can help prevent, and in some cases reverse, weight gain in youth taking second-generation antipsychotics (SGAs) for BD, according to short-term data from a large-scale trial.
The type 2 diabetes drug...
11/15/2023
Psych Congress Network
lab work
News
Dosing Starts in Pharmacokinetics Study of AD04 for Alcohol Use Disorder
07/08/2024
Jolynn Tumolo
A pharmacokinetics study of AD04, a potential treatment for AUD, is designed to meet an FDA requirement for an upcoming phase 3 trial and is expected to last 6 months.
A pharmacokinetics study of AD04, a potential treatment for AUD, is designed to meet an FDA requirement for an upcoming phase 3 trial and is expected to last 6 months.
A pharmacokinetics study of...
07/08/2024
Psych Congress Network
Stock Doctor
News
Experts Guide Aripiprazole Lauroxil Use for Tailored Schizophrenia Treatment
12/01/2023
A poster recently presented at NEI Congress 2023 suggests the use of aripiprazole lauroxil (AL), an LAI atypical antipsychotic for schizophrenia, as a versatile option supported by its pharmacokinetic, efficacy, and safety characteristics.
A poster recently presented at NEI Congress 2023 suggests the use of aripiprazole lauroxil (AL), an LAI atypical antipsychotic for schizophrenia, as a versatile option supported by its pharmacokinetic, efficacy, and safety characteristics.
A poster recently presented at...
12/01/2023
Psych Congress Network
Jonathan Meyer
Videos
The ‘Gold Standard:’ Lithium as a Mood Stabilizer for Patients With Bipolar Disorder
10/12/2023
Jonathan Meyer, MD
Dr Jonathan Meyer on lithium use in treatment
Dr Jonathan Meyer on lithium use in treatment
Dr Jonathan Meyer on lithium use...
10/12/2023
Psych Congress Network
Client at Pharmacy
News
Financial, Insurance Barriers May Interfere with Buprenorphine Dispensing at Pharmacy
04/02/2024
Jolynn Tumolo
Financial and insurance restrictions appear to deter some patients from filling buprenorphine prescriptions, according to a poster presented at the RX and Illicit Drug Summit.
Financial and insurance restrictions appear to deter some patients from filling buprenorphine prescriptions, according to a poster presented at the RX and Illicit Drug Summit.
Financial and insurance...
04/02/2024
Psychiatry & Behavioral Health

Sign Up

Psychiatry & Behavioral Health Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use